logo
Plus   Neg
Share
Email

J & J Snack Foods Expects Impact To Be Negative Due To Coronavirus

J & J Snack Foods Corp. (JJSF) said that it expects overall impact to be decidedly negative, amid the coronavirus outbreak. But the balance of its business may improve due to increased sales to grocery stores and other retailers.

The company noted that the virtual shutdown of large segments of the US economy resulting from the efforts to limit the spread of the coronavirus (COVID-19) is having a material impact on its sales and operations and that it expects its results of operations to be materially negatively impacted.

The company noted that it is unable to estimate what the impact will be although it said the impact will be material.

Earlier, the company had indicated that about 1/3 of its annual revenue was to venues and locations that it said it believed would be primarily impacted.

Following the expansion of government shutdown orders, the company now said that 2/3 of its annual revenue of about $1.2 billion is to venues and locations that have shut down or sharply curtailed their foodservice operations over the past 10 days.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
RELATED NEWS
Follow RTT